Shazib Pervaiz

Pervaiz Shazib

Appointment(s)
  • Professor, Department of Physiology
Academic Qualifications
  • PhD, Southern Methodist University, USA
  • MBBS, King Edward Medical College, Pakistan
  • Fellowship, Cancer Immunology, Harvard Medical School/Massachusetts General Hospital, USA
Research Interest(s)
  • Apoptosis
  • Autophagy
  • ROS Biology
  • Mitochondrial Metabolism
  • Bcl-2 Family
  • p53
  • Rase
  • c-myc
  • PP2A
Recent Publications
  • 1. Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., . . . Gronemeyer, H. (2018). Molecular mechanisms of cell death: Recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death and Differentiation, 25(3), 486-541. doi:10.1038/s41418-017-0012-4.
  • 2. Pohl, S. O. -G., Agostino, M., Dharmarajan, A., & Pervaiz, S. (2018). Cross Talk Between Cellular Redox State and the Antiapoptotic Protein Bcl-2. ANTIOXIDANTS & REDOX SIGNALING, 22 pages. doi:10.1089/ars.2017.7414.
  • 3. Chong, S. J. F., Lai, J. X. H., Eu, J. Q., Bellot, G. L., & Pervaiz, S. (2018). Reactive Oxygen Species and Oncoprotein Signaling-A Dangerous Liaison. ANTIOXIDANTS & REDOX SIGNALING, 36 pages. doi:10.1089/ars.2017.7441.
  • 4. Angelina, C., Tan, I. S. Y., Choo, Z., Lee, O. Z. J., Pervaiz, S., & Chen, Z. X. (2017). KIF1B beta increases ROS to mediate apoptosis and reinforces its protein expression through O-2(-) in a positive feedback mechanism in neuroblastoma. SCIENTIFIC REPORTS, 7, 10 pages. doi:10.1038/s41598-017-17192-6.
  • 5. Wong, A. L. A., Hirpara, J. L., Pervaiz, S., Eu, J. -Q., Sethi, G., & Goh, B. -C. (2017). Do STAT3 inhibitors have potential in the future for cancer therapy?. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 26(8), 883-887. doi:10.1080/13543784.2017.1351941.